A phase 2a trial investigating ninerafaxstat - a novel cardiac mitotrope for the treatment of diabetic cardiomyopathy (IMPROVE-DiCE)
26 August 2022 (14:15 - 15:00)
Organised by:
Abstract
Slides
About the speaker
Bern University Hospital, Inselspital, Bern (Switzerland)
7 More presentations in this session
Doctor A. Henry (Oxford, GB)
Miss A. Romero Valero (Elche, ES)
Doctor K. Mascherbauer (Vienna, AT)
Access the full session
The Event
ESC Congress 2022
26 August 2022
14:15 CET
You may be interested in
Congress Session
Congress Session
